Krishna Institute of Medical Sciences Limited (KIMS) has submitted a regulatory disclosure to the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure intimates the schedule of an upcoming Analyst/Institutional Investor Meeting. The meeting is scheduled for August 13, 2026. It will be a Group Meeting held at the JM Financial Centre Stage Conference in Mumbai, India.
The company explicitly states that no Unpublished Price Sensitive Information (UPSI) will be shared during this meeting. The schedule is noted as being subject to change due to any exigencies.
The communication was signed by Nagajayanthi J.R, who holds the position of Company Secretary & Compliance Officer for Krishna Institute of Medical Sciences Limited.